by Richard Daverman, PhD
November 15, 2013 -- The output from China’s pharmaceutical sector will grow 20.5% in 2013, reaching 2.3 billion RMB or $372.6 billion, according to the Southern Medicine Economic Institute, a CFDA unit. Output for the first half of the year was up 21.6%, and revenues climbed 19.5%. These figures are roughly equal to the growth in 2012. However, net income is down sharply this year. In 2012, profits were 20.4% higher in the first half of the year. That number dropped to only 16.4% in the comparable period of 2013. More details....
Help employers find you! Check out all the jobs and post your resume.
